FULL DETAILS (Read-only)  -> Click Here to Create PDF for Current Dataset of Trial
CTRI Number  CTRI/2024/10/075358 [Registered on: 16/10/2024] Trial Registered Prospectively
Last Modified On: 30/09/2024
Post Graduate Thesis  Yes 
Type of Trial  Interventional 
Type of Study   Drug
Ayurveda 
Study Design  Single Arm Study 
Public Title of Study   Effect of Abrak Yoga on Silicosis 
Scientific Title of Study   Physico Chemical Biological Characterization and Exploratory clinical trial of Abhrak Kalpa in the management of Silicosis  
Trial Acronym  NIL 
Secondary IDs if Any  
Secondary ID  Identifier 
NIL  NIL 
 
Details of Principal Investigator or overall Trial Coordinator (multi-center study)  
Name  Dr Ravi Pratap Singh 
Designation  Assistant Professor 
Affiliation  PGIA, DSRRAU, Jodhpur 
Address  Post Graduate Institute of Ayurved, DSRRAU Campus, Nagaur Road, Karwar, Jodhpur

Jodhpur
RAJASTHAN
342037
India 
Phone  7229806929  
Fax    
Email  singhravipratap276@gmail.com  
 
Details of Contact Person
Scientific Query
 
Name  Prof Pradeep Kumar Prajapati 
Designation  Vice Chancellor 
Affiliation  DSRRAU, Jodhpur 
Address  Vice Chancellor office, Dr Sarvepalli Radhakrishnan Rajasthan Ayurved University, Nagaur Road, Karwar, Jodhpur

Jodhpur
RAJASTHAN
342037
India 
Phone  9818575845  
Fax    
Email  prajapati.pradeep1@gmail.com  
 
Details of Contact Person
Public Query
 
Name  Prof Pradeep Kumar Prajapati 
Designation  Vice Chancellor 
Affiliation  DSRRAU, Jodhpur 
Address  Vice Chancellor Office, Dr Sarvepalli Radhakrishnan Rajasthan Ayurved University, Nagaur Road, Karwar, Jodhpur

Jodhpur
RAJASTHAN
342037
India 
Phone  9818575845  
Fax    
Email  prajapati.pradeep1@gmail.com  
 
Source of Monetary or Material Support  
Dr Sarvepalli Radhakrishnan Rajasthan Ayurved University, Karwar, Nagaur road, Jodhpur 
Indian Institute of Technology (IIT), Jodhpur 
 
Primary Sponsor  
Name  Post Graduate Institute of Ayurved, Jodhpur, Rajasthan 
Address  PGIA, Dr S R Rajasthan Ayurved University, Jodhpur, Rajasthan 342037 
Type of Sponsor  Research institution and hospital 
 
Details of Secondary Sponsor  
Name  Address 
Dr Ravi Pratap Singh  Near Mandore Garden, Mandore, Jodhpur, Rajasthan Pincode - 342304  
 
Countries of Recruitment     India  
Sites of Study  
No of Sites = 1  
Name of Principal Investigator  Name of Site  Site Address  Phone/Fax/Email 
Dr Ravi Pratap Singh  Sanjeevani Hospital  Room no. 10 PGIA, Dr S R Rajasthan Ayurved University Jodhpur
Jodhpur
RAJASTHAN 
7229806929

singhravipratap276@gmail.com 
 
Details of Ethics Committee  
No of Ethics Committees= 1  
Name of Committee  Approval Status 
Dr Sarvepalli Radhakrishnan Rajasthan Ayurved University, Post Graduate Institutional Committee,Institutional Ethical Committee  Approved 
 
Regulatory Clearance Status from DCGI  
Status 
Not Applicable 
 
Health Condition / Problems Studied  
Health Type  Condition 
Patients  (1) ICD-10 Condition:J628||Pneumoconiosis due to other dust containing silica. Ayurveda Condition: SVASAH,  
 
Intervention / Comparator Agent  
snoIntervention/ComparatorTypeDrug-TypeProcedure NameDetails
1Intervention ArmDrugClassical(1) Medicine Name: Abhrak Kalpa, Reference: Rasa Tarangini, Route: Oral, Dosage Form: Gutika/Vati/Ghana Vati/ Tablets, Dose: 125(mg), Frequency: bd, Bhaishajya Kal: Adhobhakta, Duration: 30 Days, anupAna/sahapAna: Yes(details: Madhu or Lukewarm water), Additional Information: -
 
Inclusion Criteria  
Age From  20.00 Year(s)
Age To  50.00 Year(s)
Gender  Both 
Details  a) Patients aged between 20-50 years of either sex presenting with clinical features of Swasa roga
having an occupational history of silicosis.
b) Pre-diagnosed silicosis patient.
c) Patient willing to sign a consent form.  
 
ExclusionCriteria 
Details  a) Age below 20 and above 50 years.
b) Patients suffering from tuberculosis.
c) Chronic systemic illness like Carcinoma etc.
d) Patient having Major Renal or Liver disorders.
e) Mentally challenged individuals.  
 
Method of Generating Random Sequence   Other 
Method of Concealment   Other 
Blinding/Masking   Open Label 
Primary Outcome  
Outcome  TimePoints 
change in subjective & objective parameters for silicosis  30 days  
 
Secondary Outcome  
Outcome  TimePoints 
improvement in the quality of life of the patients.   30 days 
 
Target Sample Size   Total Sample Size="30"
Sample Size from India="30" 
Final Enrollment numbers achieved (Total)= "Applicable only for Completed/Terminated trials"
Final Enrollment numbers achieved (India)="Applicable only for Completed/Terminated trials" 
Phase of Trial   Phase 2/ Phase 3 
Date of First Enrollment (India)   15/07/2025 
Date of Study Completion (India) Applicable only for Completed/Terminated trials 
Date of First Enrollment (Global)  Date Missing 
Date of Study Completion (Global) Applicable only for Completed/Terminated trials 
Estimated Duration of Trial   Years="0"
Months="1"
Days="0" 
Recruitment Status of Trial (Global)   Not Applicable 
Recruitment Status of Trial (India)  Not Yet Recruiting 
Publication Details   N/A 
Individual Participant Data (IPD) Sharing Statement

Will individual participant data (IPD) be shared publicly (including data dictionaries)?  

Response - NO
Brief Summary   It is generally accepted that the pathogenesis of pulmonary fibrosis is characterized by persistent micro-damage to the alveolar epithelium with an abnormal repair process. This process is characterized by abnormal activation of myofibroblasts, excessive accumulation of ECM, and lung scar formation, ultimately leading to structural destruction and loss of lung function. [xv] Ayurveda prescribes a holistic approach to treating the disease or syndrome. Bioactive fractions from medicinal plants that treat multiple diseases could exert their effects by targeting common pathways. Hence, a definitive need is to introduce traditional formulation to combat silicosis, associated disorders, or the probable links with diseases. Silicosis has a complex disease; it is very tough to correlate with a single disorder in Ayurveda literature.  
Close